- Home
- VRME vs MTVA Comparison
VRME vs MTVA Comparison
Compare VRME & MTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRME
- MTVA
- Stock Information
- Founded
- VRME 1999
- MTVA 2014
- Country
- VRME United States
- MTVA United States
- Employees
- VRME N/A
- MTVA N/A
- Industry
- VRME EDP Services
- MTVA
- Sector
- VRME Technology
- MTVA
- Exchange
- VRME Nasdaq
- MTVA NYSE
- Market Cap
- VRME 15.1M
- MTVA 16.8M
- IPO Year
- VRME N/A
- MTVA N/A
- Fundamental
- Price
- VRME $0.94
- MTVA $1.60
- Analyst Decision
- VRME Buy
- MTVA Strong Buy
- Analyst Count
- VRME 1
- MTVA 1
- Target Price
- VRME $1.50
- MTVA $12.00
- AVG Volume (30 Days)
- VRME 986.2K
- MTVA 23.0K
- Earning Date
- VRME 03-20-2025
- MTVA 03-27-2025
- Dividend Yield
- VRME N/A
- MTVA N/A
- EPS Growth
- VRME N/A
- MTVA N/A
- EPS
- VRME N/A
- MTVA N/A
- Revenue
- VRME $25,259,000.00
- MTVA N/A
- Revenue This Year
- VRME N/A
- MTVA N/A
- Revenue Next Year
- VRME $5.00
- MTVA N/A
- P/E Ratio
- VRME N/A
- MTVA N/A
- Revenue Growth
- VRME N/A
- MTVA N/A
- 52 Week Low
- VRME $0.58
- MTVA $1.51
- 52 Week High
- VRME $5.00
- MTVA $6.75
- Technical
- Relative Strength Index (RSI)
- VRME 37.82
- MTVA N/A
- Support Level
- VRME $0.95
- MTVA N/A
- Resistance Level
- VRME $1.22
- MTVA N/A
- Average True Range (ATR)
- VRME 0.10
- MTVA 0.00
- MACD
- VRME -0.05
- MTVA 0.00
- Stochastic Oscillator
- VRME 5.78
- MTVA 0.00
About VRME VerifyMe Inc.
VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.